5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione (BRL49653) for treating non-insulin dependent diabetes (NIDDM)

摘要

A combination comprises from 2-12 mg of 5-[4-[2-(N- methyl-N-(2-pyridyl)amino)ethoxy] benzyl]thiazolidine-2,4- dione) or a pharmaceutically acceptable form and insulin. The combination can be used in the manufacture of a medicament for the treatment of diabetes mellitus.